Education
About Us
Working with TipRanks
Follow Us
Robert James Wills Insider Profile
4 Followers
Robert James Wills, Director at Oncternal Therapeutics, holds 15.00K shares in Alpha Cognition Inc (Ticker: ACOG), holds 65.00K shares in Milestone Pharmaceuticals (Ticker: MIST), holds 10.00K shares in Oncternal Therapeutics (Ticker: ONCT). Most recently, Robert James Wills Bought ― shares of Alpha Cognition Inc on Aug 21, 2025 for an estimated value of $127.20K.
Robert James Wills Oncternal Therapeutics (ONCT)Director
Oncternal Therapeutics (ONCT)
Director
Ranked #56,608 out of 103,431 Corporate Insiders
Profitable Transactions
4 out of 10 Profitable Transactions
Average Return
-1.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert James Wills holds in companies
Most Profitable Insider Trade
Stock:
CymaBay Therapeutics
(CBAY)
(CBAY)
Rating:Informative Buy
Date:Sep 09, 2016 - Sep 09, 2017
Return:+155.30%
The most profitable trade made by Robert James Wills
Robert James Wills's Trading History
Oncternal Therapeutics
Apr 10, 2024
―
Informative Buy
27.65K
$5.26K
Milestone Pharmaceuticals
Jul 15, 2025
Director
Uninformative Buy
―
$111.80K
Alpha Cognition Inc
Aug 21, 2025
Director
Informative Buy
127.20K
$146.70K
CymaBay Therapeutics
Mar 22, 2024
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Robert James Wills's performance on stock
You May Also Like
Robert James Wills insider profile FAQ
What is the percentage of profitable transactions made by Robert James Wills?
The percentage of profitable transactions made by Robert James Wills is 40%.
What is the average return per transaction made by Robert James Wills?
The average return per transaction made by Robert James Wills is -1.60%.
What stocks does Robert James Wills hold?
Robert James Wills holds: ONCT, MIST, ACOG, CBAY stocks.
What was Robert James Wills’s latest transaction?
Robert James Wills latest transaction was an Informative Buy of $127.20K.
What was Robert James Wills's most profitable transaction?
Robert James Wills’s most profitable transaction was an Informative Buy of CBAY stock on September 9, 2016. The return on the trade was 155.30%.
What is Robert James Wills's role in Oncternal Therapeutics?
Robert James Wills's role in Oncternal Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.